News
Sickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for causing anaemia, pain episodes, and organ complications, but a lesser ...
WASHINGTON ― President Donald Trump said he will sign an executive order that institutes a "most favored nation" policy for drug pricing, reviving a plan from his first term that he said will ...
Best credit card sign-up bonuses of May 2025 Best for 0% APR: Wells Fargo Active Cash® Card Best for flexible rewards: Chase Sapphire Preferred® Card (See rates and fees) Best for premium perks ...
What is important to understand is that everyone — even current subscribers — will need to sign up for this service. Our old Breaking News text alert system will end August 31st. To sign up ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
Brevis has been brought in as a replacement for pacer Gurjapneet Singh. They were able to sign the South African as the replacement since there was one overseas slot left in their roster.
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
Senior medical analyst Dr. Marc Siegel discusses the Trump administration's efforts to reduce drug prices and Hamas saying it will release its last American hostage, Edan Alexander.
The Raiders’ rookie minicamp concluded today. In addition to the drafted rookies and undrafted free agent rookies who were in attendance, Las Vegas also hosted players to participate in rookie ...
Scedamin is a pediatric formulation of hydroxyurea being developed by Yunigen Inc. Scedamin is a pediatric formulation of hydroxyurea designed to treat children aged nine months and older who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results